Riskpilot← Back to searchSign inGet full accessXU MEDICAL AS
ASActiveOrg 995356708Kirkeveien 133D, 1344 HaslumGeneral medical practice activities · NACE 8621Est. 20102 employees
Revenue 2024
NOK 6,1M
-26% vs 2023
EBITDA margin
17.7%
-66% vs 2023
Equity ratio
3.3%
Financial strength
Net profit 2024
NOK 821K
-66% vs 2023
| Revenue | NOK 6,1M | -26% |
| EBITDA | NOK 1,1M | -66% |
| Net profit | NOK 821K | -66% |
| Total assets | NOK 3M | -35% |
| Equity | NOK 100K | +0% |
| Employees | 2 | — |
Legal name
XU MEDICAL AS
Org number
995356708
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
30. mars 2010
Share capital
NOK 100 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Legevirksomhet, kurs-, foredrags- og undervisningsvirksomhet, utarbeidelse av spesialisterklæringer og sakkyndige oppdrag, konsulentvirksomhet.
Address
Kirkeveien 133D, 1344 Haslum
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 1 305 | 1 401 | 1 124 | 2 294 | 2 137 | 3 363 | 3 956 | 5 019 | 4 389 | 4 088 | 4 467 | 6 569 | 6 568 | 8 202 | 6 105 |
| Staff expenses | −0 | −378 | −729 | −1 020 | −373 | −227 | −980 | −1 095 | −1 378 | −1 523 | −2 090 | −2 234 | −2 300 | −2 646 | −2 486 | −3 734 |
| EBITDA | 0 | 664 | 326 | −832 | 901 | 820 | 1 132 | 1 575 | 2 271 | 1 577 | 679 | 995 | 2 992 | 1 892 | 3 141 | 1 081 |
| Depreciation & amort. | −0 | −0 | −0 | −66 | −87 | −97 | −100 | −100 | −47 | −1 | −0 | −0 | −4 | −11 | −12 | −12 |
| EBIT | 0 | 664 | 326 | −899 | 813 | 722 | 1 033 | 1 475 | 2 223 | 1 576 | 679 | 995 | 2 988 | 1 881 | 3 129 | 1 069 |
| Net financials | 0 | 8 | 3 | −1 | 1 | 0 | −15 | −10 | −8 | −8 | 0 | 2 | −0 | −11 | −16 | −26 |
| Profit before tax | 0 | 672 | 329 | −899 | 814 | 723 | 1 018 | 1 465 | 2 215 | 1 568 | 679 | 997 | 2 988 | 1 870 | 3 113 | 1 042 |
| Tax | −0 | 187 | 93 | −0 | −0 | 178 | 290 | 381 | 535 | 355 | 145 | 215 | 654 | 411 | 685 | 222 |
| Net profit | 0 | 485 | 236 | −899 | 814 | 545 | 728 | 1 084 | 1 680 | 1 213 | 534 | 781 | 2 335 | 1 459 | 2 428 | 821 |
| Item | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 108 | 869 | 1 265 | 1 395 | 1 983 | 3 358 | 4 201 | 4 850 | 3 967 | 2 946 | 1 448 | 1 761 | 3 750 | 5 093 | 4 570 | 2 989 |
| Equity | 100 | 585 | 821 | −78 | 736 | 1 281 | 2 009 | 593 | 773 | 187 | 221 | 1 002 | 2 587 | 956 | 100 | 100 |
| Long-term debt | 0 | 0 | 0 | 430 | 430 | 430 | 340 | 280 | 840 | 333 | 260 | 102 | 128 | 300 | 0 | 885 |
| Short-term debt | 8 | 284 | 444 | 1 043 | 816 | 1 647 | 1 853 | 3 977 | 2 354 | 2 427 | 967 | 657 | 1 036 | 3 836 | 4 470 | 2 004 |
| Total debt | 8 | 284 | 444 | 1 473 | 1 246 | 2 077 | 2 193 | 4 257 | 3 194 | 2 760 | 1 227 | 759 | 1 163 | 4 136 | 4 470 | 2 889 |
EBITDA margin
17.7%
This company
15.8%
Market median
+12% vs market
20092024
Equity ratio
3.3%
This company
38.2%
Market median
-91% vs market
20092024
Return on equity
820.6%
This company
18.4%
Market median
+4360% vs market
20092024
Net profit margin
13.4%
This company
8.1%
Market median
+65% vs market
20092024
Asset turnover
2.04×
This company
1.12×
Market median
+82% vs market
20092024
Debt / equity
28.89×
This company
0.62×
Market median
-4560% vs market
20092024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TM Chief Executive Officer | Chief Executive Officer | 2010 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JX | Board of Directors | 2010 | — | — |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2010 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Xu Capital As | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Xu Capital As
XU MEDICAL AS Board members of XU MEDICAL AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tehua Michael Xu | Chief Executive Officer | 0 companies |
| Jin Xu | Board of Directors | 0 companies |
| Wenhui Jiang | Board of Directors | 0 companies |
| Mei Fang Zhang | Board of Directors | 0 companies |